ImportRefusal LogoImportRefusal

Meda Pharma Gmbh & Co. KG

⚠️ Moderate Risk

FEI: 3003569806 • Bad Homburg, Hesse • GERMANY

FEI

FEI Number

3003569806

📍

Location

Bad Homburg, Hesse

🇩🇪

Country

GERMANY
🏢

Address

Benzstr. 1, , Bad Homburg, Hesse, Germany

Moderate Risk

FDA Import Risk Assessment

47.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

7
Total Refusals
5
Unique Violations
12/8/2023
Latest Refusal
4/4/2006
Earliest Refusal

Score Breakdown

Violation Severity
70.8×40%
Refusal Volume
33.5×30%
Recency
43.8×20%
Frequency
4.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

756×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4722×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

Refusal History

DateProductViolationsDivision
12/8/2023
61SCY04PIMECROLIMUS
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/19/2018
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/10/2016
66CBY99STOOL SOFTENER N.E.C.
118NOT LISTED
472NO ENGLISH
75UNAPPROVED
Cincinnati District Office (CIN-DO)
9/16/2015
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
27DRUG GMPS
472NO ENGLISH
75UNAPPROVED
Cincinnati District Office (CIN-DO)
10/12/2012
60CCK04EPINEPHRINE (ADRENERGIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/19/2011
65QDA12CHLORPHENOXAMINE HCL (RELAXANT)
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/4/2006
61XDS99ANTI-HISTAMINIC N.E.C.
118NOT LISTED
16DIRECTIONS
New York District Office (NYK-DO)

Frequently Asked Questions

What is Meda Pharma Gmbh & Co. KG's FDA import refusal history?

Meda Pharma Gmbh & Co. KG (FEI: 3003569806) has 7 FDA import refusal record(s) in our database, spanning from 4/4/2006 to 12/8/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Meda Pharma Gmbh & Co. KG's FEI number is 3003569806.

What types of violations has Meda Pharma Gmbh & Co. KG received?

Meda Pharma Gmbh & Co. KG has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Meda Pharma Gmbh & Co. KG come from?

All FDA import refusal data for Meda Pharma Gmbh & Co. KG is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.